Company Monitoring Page for Roche

latest headlines for company on cafepharma

Novartis, Roche CEOs see performance-based future, but U.S. isn't ready yet
Fierce Biotech
Fri, 11/13/15 - 10:00 am
Tags:
Novartis, Roche, Pharma CEOs, Amgen, Repatha, Joe Jimenez, Severin Schwan
Roche inks $83M iPSC pact with Cellular Dynamics
Fierce Biotech
Thu, 11/12/15 - 09:15 am
Tags:
Roche, Cellular Dynamics, stem cells
How Roche is applying immunotherapy techniques to fight bacterial infections
BioPharma Dive
Fri, 11/6/15 - 10:42 am
Tags:
Roche, immunotherapy, antibody–antibiotic conjugate, antibiotics
Is Inovio Pharmaceuticals a Late Bloomer?
Motley Fool
Sat, 10/31/15 - 10:07 am
Tags:
Inovio, VGX-3100, Roche, AstraZeneca
The top 10 biopharma pipeline disasters of 2015
Fierce Biotech
Fri, 10/30/15 - 09:55 am
Tags:
Eli Lilly, GSK, AstraZeneca, Shire, Celladon, Takeda, Merck, Roche, Verastem, evacetrapib, Breo Ellipta, brodalumab, selumetinib, SHP625, Mydicar, Alisertib, suggammadex, sembragiline, Defactinib
Old standbys deliver for Roche in Q3 while Esbriet, Perjeta come on strong
Fierce Pharma
Thu, 10/22/15 - 07:23 pm
Tags:
Roche, earnings
ImmunoGen, Roche gastric cancer drug fails study
Yahoo/Reuters
Thu, 10/22/15 - 09:54 am
Tags:
Immunogen, Roche, gastric cancer, clinical trials, Kadcyla
Did Roche Unleash Biogen's Worst Nightmare?
Motley Fool
Tue, 10/20/15 - 05:55 pm
Tags:
Roche, Biogen, MS, multiple sclerosis, ocrelizumab
One man, an army of contractors and a half-billion-dollar deal with Genentech's parent
Bizjournals.com
Sat, 10/10/15 - 09:10 am
Tags:
Genentech, Roche
Experts push for trials to evaluate Roche, GSK flu drugs' pandemic potential
Fierce Pharma
Fri, 10/9/15 - 10:07 am
Tags:
Roche, GSK, influenza, R&D
Roche drug may set new benchmark in MS, data suggest
Yahoo/Reuters
Thu, 10/8/15 - 12:31 pm
Tags:
Roche, multiple sclerosis, MS, ocrelizumab
Roche CEO: Big Data needs Big Pharma, and vice versa
Fierce Pharma
Tue, 10/6/15 - 07:03 pm
Tags:
Roche, Big Pharma, Big Data, Severin Schwan
Roche poised for MS coup with PhIII success in progressive disease
Fierce Pharma
Thu, 10/1/15 - 05:27 pm
Tags:
MS, multiple sclerosis, Roche, ocrelizumab
Innovation Remains Best Remedy In Drug Pricing Debate
Forbes
Wed, 09/30/15 - 09:35 am
Tags:
innovation, drug pricing, ocrelizumab, Roche
Roche says new drug shows benefits in lung, bladder cancer tests
Yahoo/Reuters
Sun, 09/27/15 - 08:47 pm
Tags:
Roche, lung cancer, bladder cancer, atezolizumab
Roche is 'well placed' for U.S. pricing tussle, CEO says
Fierce Pharma
Sun, 09/27/15 - 08:42 pm
Tags:
Roche, drug pricing, Severin Schwan
Roche-partnered Oryzon plans Madrid IPO as launchpad to Nasdaq
Fierce Biotech
Fri, 09/18/15 - 10:48 am
Tags:
Roche, Oryzon, IPOs, Spain, epigenetics
Roche preps for make-or-break MS data with eyes on a crowded space
Fierce Biotech
Thu, 09/17/15 - 05:19 pm
Tags:
Roche, MS, multiple sclerosis, ocrelizumab
Roche says biotech 'bubble' pushes midsize buys out of reach
Yahoo/Reuters
Wed, 09/16/15 - 08:49 am
Tags:
Roche, biotech, M&A, Severin Schwan
Roche Chief Takes Long View as Real's Slide, China Slowdown Hurt
Bloomberg
Tue, 09/8/15 - 02:09 pm
Tags:
Roche, Severin Schwan, emerging markets, China

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.